Scopulariopsis brevicaulis is a soil saprophytic mould. This non-dermatophytic filamentous fungus colonises plantar, animal and human tissues (Filipello Marchisio et al., 2000) . Traditionally, it has not been considered a common human pathogen. However, the number of cases showing its pathogenicity is still increasing. The most common type of infection caused by S. brevicaulis is onychomycosis. Its prevalence is estimated to be 3-10% of total number of onychomycosis cases. The clinical manifestation is generally recognised as distal and lateral subungual onychomycosis (DLSO) (Stefanato and Verdolini, 2009; Gupta et al., 2012) . There are also cases of smooth skin and sub cutaneous tissue infections caused by S. brevicaulis (Dhar and Carey, 1993; Bryuynzel and Starink, 1998; Anandan et al., 2008) . Moreover, S. brevicaulis has been reported as the cause of such infections as endocarditis (Gentry et al., 1995; Migriono et al., 1995; Jain et al., 2011) , keratitis (Del Prete et al., 1994; Lotery et al., 1994) , endo phthalmitis (Gariano and Kalina, 1997) , sinusitis (Gluck et al., 2011) , fungus ball (Endo et al., 2002; Satyavani et al., 2010) , otomycosis (Hennequin et al., 1994; Besbes et al., 2002) , pneumonia (Issakainen et al., 2010) , cerebral phaeohyphomycosis and brain abscess (Hart et al., 2001) , disseminated infection causing skin lesions including a patient with acquired immune deficiency syndrome (AIDS) (Dhar and Carey, 1993) , disseminated infections after bone marrow transplant (Neglia et al., 1987; Phillips et al., 1989; Krisher et al., 1995) and after lung transplant (Wuyts et al., 2005) . Disseminated S. brevicaulis infections are hard to treat and have high mortality rates, especially in immunocompromised patients. S. brevicaulis disseminated infections might be clinically and histologically indistinguishable from disseminated aspergillosis, fusariosis or zygomycosis (Salmon et al., 2010; Swick et al., 2010; Vignon et al., 2011) . The data considering S. brevicau lis susceptibility are scarce and often inconsistent. The reports indicate that S. brevicaulis is a multi resistant fungus (Cuenca-Estrella et al., 2003) .
In this paper we present a PCR-based method developed for the detection of S. brevicaulis. By a two-step extraction procedure followed by PCR and electrophoresis, the method enables fast identification of this pathogen.
Reference Table I ). All isolates were identified by observation of macro-and micromorphology. Isolates were cultured on Sabouraud medium (Biomerieux, France) and incubated for up to 14 days at room temperature. DNA from samples (pieces of mycelium of 3-5 mm diameter) was extracted by a 10-min incubation of the sample in 100 µl of extraction buffer (60 mM sodium bicarbonate [NaHCO 3 ], 250 mM potassium chloride [KCl] and 50 mM Tris, pH 9.5) in 95°C and subsequent addition of 100 µl anti-inhibition buffer (2% bovine serum albumin). After vortex mixing, this DNAcontaining solution was used for PCR (BrillowskaDąbrowska et al., 2010) . Reagents were, unless otherwise stated, purchased from Sigma (Germany).
On the basis of alignment (VectorNTI; InforMax, Inc., USA) of sequences of β-tubulin gene presented in the NCBI nucleotide database, S. brevicaulis -specific primers Sbfor (5' AACAAACCCACTTCC-CGTCGTTT3') and Sbrev (5' ACATATTTGTTTCC-CGAAGCCTTTAG3') were designed. One S. brevicau (Table I) were tested. 20 µl PCR mixtures consisted of 10 µl of 2 × PCR Master Mix Plus High GC (A&A Biotechnology, Poland), 0,1 µl of each primer (Sbfor, Sbrev -Genomed, Poland) at 100 µM, and 2 µl of DNA. PCR was performed in a Mastercycler ep gradient S-5345 (Eppendorf, Germany). The time-temperature profile for PCR started with initial denaturation for 3 min 94°C followed by 35 cycles of 30 s at 94°C, 30 s at 60°C, and 30 s at 72°C. The presence of specific PCR products of 223 bp was examined using electrophoresis on a 2% agarose gel and staining with ethidium bromide.
A 223-bp PCR product corresponding to S. brevi caulis was observed for 5/5 S. brevicaulis DNA samples. No PCR products were detected for S. asperula, S. cinerea, S. fusca reference strains, 56 other mould isolates, 65 dermatophyte isolates, 30 yeast-like isolates and one purified human DNA (100% sensitivity and 100% specificity for PCR) (Fig. 1) .
Nowadays, S. brevicaulis identification is based on macro-and microscopic observations. As these methods are laborious, time-consuming and requiring a pure culture for correct identification, they often produce misleading results (Jagielski et al., 2013) . Especially diagnosis of disseminated S. brevicaulis infections is challenging for several reasons. First, disseminated S. brevicaulis infection is clinically difficult to distinguish from disseminated infection caused by Aspergillus, Fusarium and zygomycosis. Second, in the immunocompromised organ transplant patient the sensitivity of confirmatory blood cultures is poor. There is no rapid blood test to confirm Scopulariopsis infection. Third, histopathologic evaluation of a cutaneous biopsy from a suspicious cutaneous lesion is not able to distinguish one disseminated mycelial infection from another. Aspergillus, Fusarium and other hyalohyphomycoses such as Scopulariopsis show identical morphology of biopsy specimens. To enable differentiation between the above listed mycelial fungi the tissue should be submitted for culture studies at the time of biopsy that delays the diagnosis for at least 1 week (Swick et al., 2010) . So far, sequencing (Jagielski et al., 2013) and RFLP (Bontems et al., 2009) are the only molecular methods described for S. brevicaulis identification. However, these methods are still laborious and time-consuming. All of these factors indicate the need for development of methods that provide simple, rapid and highly specific identification of S. brevicaulis. In this study we present a PCR-based method that enables specific detection of S. brevicaulis within few hours. Application of primers Sbfor and Sbrev in PCR gives correct results among tested isolates. This potential of the described method as the diagnostic test should be evaluated further by testing patient specimens, because the applied procedure enables DNA extraction directly from specimens thus significantly reducing the time of diagnosis (Brillowska-Dąbrowska et al., 2010) . 
